CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to investigate the efficacy and safety of the lifileucel regimen in participants with previously treated endometrial...
Phase 2
Orlando, Florida, United States and 11 other locations
and safety of T-DXd adjuvant therapy, with or without radiotherapy, post-surgery in anticancer treatment naïve (including neoadjuvant therapy) endometrial...
Phase 3
Orlando, Florida, United States and 85 other locations
study to assess safety, tolerability, pharmacokinetics, immunogenicity, and antitumor activity of ARR-002 in advanced or metastatic ovarian or endometrial...
Phase 1
Orlando, Florida, United States and 5 other locations
(MMR) system, that fixes genetic mistakes. In most endometrial cancers, this system works normally, and these cancers are ...
Phase 3
Orlando, Florida, United States and 53 other locations
This is a Phase III, 2-arm, randomized, open label, multicenter, global study assessing the efficacy and safety of puxitatug samrotecan compared to p...
Phase 3
Orlando, Florida, United States and 318 other locations
letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until eit...
Phase 2
Orlando, Florida, United States and 29 other locations
fulvestrant in patients with PIK3CA-mutated ER-positive endometrioid endometrial cancers by estimating the objective response rate ...
Phase 2
Orlando, Florida, United States and 20 other locations
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
Orlando, Florida, United States and 243 other locations
DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...
Phase 3
Orlando, Florida, United States and 255 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Orlando, Florida, United States and 168 other locations
Clinical trials
Research sites
Resources
Legal